Filters close
Released: 7-Dec-2017 3:00 PM EST
Drug Offers New Hope to Fight Relapse in People with Kidney Cancer
University of California, Los Angeles (UCLA), Health Sciences

Sunitinib (marketed as Sutent) a drug that has already proven highly effective as first-line treatment for people with metastatic renal cell carcinoma, was recently approved by the U.S. Food and Drug Administration to also treat patients with the disease who are at high risk for tumor recurrence.

Released: 7-Dec-2017 11:05 AM EST
WashU Expert: Incentivizing New Uses for Off-Patent Drugs
Washington University in St. Louis

Generic medications could be an effective way to improve health outcomes while lowering costs, but the existing drug patent system is poorly designed to motivate such discoveries, says an expert on health law at Washington University in St. Louis.“Additional testing and approvals are common for expensive on-patent drugs, but we don’t often seek out new uses for less expensive generic drugs, since it can be more difficult to profit from the research,” said Rachel Sachs, associate professor of law.



close
0.67094